Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland Company News
Bristol Myers Squibb Announces Positive Topline Results of Phase 3 COMMANDS Trial Pharmaceutical Investing
Aurinia Pharmaceuticals to Release Third Quarter 2022 Financial and Operational Results on November 3, 2022 Pharmaceutical Investing
AbbVie Announces Submissions of Regulatory Applications for Epcoritamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Large B-Cell Lymphoma Pharmaceutical Investing
Obsidian Therapeutics Announces Extension of Multi-Year Collaboration Agreement with Bristol Myers Squibb Pharmaceutical Investing
New Zeposia Data Highlight COVID-19 Outcomes and Preservation of Long-Term Cognitive Function from Separate Analyses in Patients with Relapsing Forms of Multiple Sclerosis Pharmaceutical Investing
